• LAST PRICE
    6.0401
  • TODAY'S CHANGE (%)
    Trending Down-0.1199 (-1.9464%)
  • Bid / Lots
    6.0200/ 1
  • Ask / Lots
    6.2700/ 3
  • Open / Previous Close
    6.3900 / 6.1600
  • Day Range
    Low 5.9300
    High 6.4000
  • 52 Week Range
    Low 2.6200
    High 9.9870
  • Volume
    10,417
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 6.16
TimeVolumeBNR
09:32 ET4616.39
09:33 ET15106
09:37 ET1006.4
11:21 ET19026.34
11:39 ET2006.15
11:43 ET10876.33
11:56 ET3006.1457
12:12 ET1006.27
01:22 ET2005.93
01:31 ET1006.27
02:07 ET1006.2256
02:36 ET2006.0408
02:41 ET2006.0401
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBNR
Burning Rock Biotech Ltd
62.0M
-0.1x
---
United StatesOTRK
Ontrak Inc
7.4M
-0.2x
---
United StatesHLYK
Healthlynked Corp
10.1M
-1.5x
---
United StatesPFHO
Pacific Health Care Organization Inc
10.7M
12.3x
-10.80%
United StatesIVP
Inspire Veterinary Partners Inc
7.1M
0.0x
---
United StatesKDLY
Kindly MD Inc
6.8M
-2.1x
---
As of 2024-12-03

Company Information

Burning Rock Biotech Ltd is a holding company mainly engaged in the next generation sequencing (NGS) based cancer therapy selection. The Company operates three segments. Central Laboratory Business segment is engaged in the sales of cancer therapy selection test to individual patients. In-Hospital Business segment is engaged in the sales of reagent kits and the provision of the facilitation services for the sale of laboratory equipment to hospitals. Pharma Research and Development Services segment provide services to companies primarily in relation to the development of targeted therapies and immunotherapies for various types of cancer, and to hospitals for their studies on cancer diagnosis and treatment. Its products include OncoScreen Plus and LungPlasma. Its NGS-based cancer therapy selection tests applicable to a broad range of cancer types, including lung cancer, prostate cancer, breast cancer and others. The Company mainly conducts its businesses in the China market.

Contact Information

Headquarters
No. 5 Xingdao Ring Road North International Bio IslandGUANGZHOU, GNG, China 510005
Phone
---
Fax
---

Executives

Chairman of the Board, Chief Executive Officer, Founder
Yusheng Han
Chief Financial Officer, Director
Leo Li
Chief Technology Officer, Director
Zhihong Zhang
Director
Feng Deng
Director
Gang Lu

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$62.0M
Revenue (TTM)
$70.1M
Shares Outstanding
1.0M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.60
EPS
$-48.38
Book Value
$10.32
P/E Ratio
-0.1x
Price/Sales (TTM)
0.9
Price/Cash Flow (TTM)
---
Operating Margin
-114.20%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.